{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T16:57:29Z","timestamp":1770483449911,"version":"3.49.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,7,15]],"date-time":"2010-07-15T00:00:00Z","timestamp":1279152000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1007\/s10620-010-1331-1","type":"journal-article","created":{"date-parts":[[2010,7,14]],"date-time":"2010-07-14T21:11:50Z","timestamp":1279141910000},"page":"853-859","source":"Crossref","is-referenced-by-count":13,"title":["CARD15 Mutations and Perianal Fistulating Crohn\u2019s Disease: Correlation and Predictive Value of Antibiotic Response"],"prefix":"10.1007","volume":"56","author":[{"given":"Paulo","family":"Freire","sequence":"first","affiliation":[]},{"given":"Francisco","family":"Portela","sequence":"additional","affiliation":[]},{"given":"Maria M.","family":"Donato","sequence":"additional","affiliation":[]},{"given":"Manuela","family":"Ferreira","sequence":"additional","affiliation":[]},{"given":"Paulo","family":"Andrade","sequence":"additional","affiliation":[]},{"given":"Carlos","family":"Sofia","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2010,7,15]]},"reference":[{"key":"1331_CR1","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/j.1365-2036.2004.01917.x","volume":"19","author":"DA Schwartz","year":"2004","unstructured":"Schwartz DA, Herdman CR. Review article: the medical treatment of Crohn\u2019s perianal fistulas. Aliment Pharmacol Ther. 2004;19:953\u2013967.","journal-title":"Aliment Pharmacol Ther"},{"key":"1331_CR2","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1136\/gut.21.6.525","volume":"21","author":"G Hellers","year":"1980","unstructured":"Hellers G, Bergstrand O, Ewerth S, Holmstr\u00f6m B. Occurrence and outcome after primary treatment of anal fistulae in Crohn\u2019s disease. Gut. 1980;21:525\u2013527.","journal-title":"Gut"},{"key":"1331_CR3","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1053\/gast.2002.32362","volume":"122","author":"DA Schwartz","year":"2002","unstructured":"Schwartz DA, Loftus EV Jr, Tremaine WJ, et\u00a0al. The natural history of fistulizing Crohn\u2019s disease in Olmsted County, Minnesota. Gastroenterology. 2002;122:875\u2013880.","journal-title":"Gastroenterology"},{"key":"1331_CR4","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/ncpgasthep1340","volume":"6","author":"OH Nielsen","year":"2009","unstructured":"Nielsen OH, Rogler G, Hahnloser D, Thomsen O\u00d8. Diagnosis and management of fistulizing Crohn\u2019s disease. Nat Clin Pract Gastroenterol Hepatol. 2009;6:92\u2013106.","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"1331_CR5","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/ibd.20901","volume":"15","author":"F Magro","year":"2009","unstructured":"Magro F, Portela F, Lago P, et\u00a0al. Crohn\u2019s disease in a southern European country: montreal classification and clinical activity. Inflamm Bowel Dis. 2009;15:1343\u20131350.","journal-title":"Inflamm Bowel Dis"},{"key":"1331_CR6","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.gastro.2003.08.024","volume":"125","author":"American Gastroenterological Association Clinical Practice Committee","year":"2003","unstructured":"American Gastroenterological Association Clinical Practice Committee. American Gastroenterological Association medical position statement: perianal Crohn\u2019s disease. Gastroenterology. 2003;125:1503\u20131507.","journal-title":"Gastroenterology"},{"key":"1331_CR7","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1046\/j.1365-2036.2003.01561.x","volume":"17","author":"SJ Bell","year":"2003","unstructured":"Bell SJ, Williams AB, Wiesel P, Wilkinson K, Cohen RC, Kamm MA. The clinical course of fistulating Crohn\u2019s disease. Aliment Pharmacol Ther. 2003;17:1145\u20131151.","journal-title":"Aliment Pharmacol Ther"},{"key":"1331_CR8","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/00054725-200303000-00003","volume":"9","author":"M Regueiro","year":"2003","unstructured":"Regueiro M, Mardini H. Treatment of perianal fistulizing Crohn\u2019s disease with infliximab alone or as an adjunct to exam under anesthesia with seton placement. Inflamm Bowel Dis. 2003;9:98\u2013103.","journal-title":"Inflamm Bowel Dis"},{"key":"1331_CR9","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/BF02054696","volume":"39","author":"HJ Scott","year":"1996","unstructured":"Scott HJ, Northover JM. Evaluation of surgery for perianal Crohn\u2019s fistulas. Dis Colon Rectum. 1996;39:1039\u20131043.","journal-title":"Dis Colon Rectum"},{"key":"1331_CR10","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s10350-004-6611-4","volume":"46","author":"DR Topstad","year":"2003","unstructured":"Topstad DR, Panaccione R, Heine JA, Johnson DR, MacLean AR, Buie WD. Combined seton placement, infliximab infusion, and maintenance immunosuppressives improve healing rate in fistulizing anorectal Crohn\u2019s disease: a single center experience. Dis Colon Rectum. 2003;46:577\u2013583.","journal-title":"Dis Colon Rectum"},{"key":"1331_CR11","doi-asserted-by":"crossref","first-page":"i36","DOI":"10.1136\/gut.2005.081950c","volume":"55","author":"R Caprilli","year":"2006","unstructured":"Caprilli R, Gassull MA, Escher JC, et\u00a0al. European evidence based consensus on the diagnosis and management of Crohn\u2019s disease: special situations. Gut. 2006;55:i36\u2013i58.","journal-title":"Gut"},{"key":"1331_CR12","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1046\/j.1365-2036.2003.01793.x","volume":"18","author":"C Dejaco","year":"2003","unstructured":"Dejaco C, Harrer M, Waldhoer T, Miehsler W, Vogelsang H, Reinisch W. Antibiotics and azathioprine for the treatment of perianal fistulas in Crohn\u2019s disease. Aliment Pharmacol Ther. 2003;18:1113\u20131120.","journal-title":"Aliment Pharmacol Ther"},{"key":"1331_CR13","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0016-5085(82)80332-6","volume":"83","author":"LJ Brandt","year":"1982","unstructured":"Brandt LJ, Bernstein LH, Boley SJ, Frank MS. Metronidazole therapy for perineal Crohn\u2019s disease: a follow-up study. Gastroenterology. 1982;83:383\u2013387.","journal-title":"Gastroenterology"},{"key":"1331_CR14","first-page":"533","volume":"79","author":"J Jakobovits","year":"1984","unstructured":"Jakobovits J, Schuster MM. Metronidazole therapy for Crohn\u2019s disease and associated fistulae. Am J Gastroenterol. 1984;79:533\u2013540.","journal-title":"Am J Gastroenterol"},{"key":"1331_CR15","first-page":"A793","volume":"104","author":"U Turumen","year":"1993","unstructured":"Turumen U, Fakkila M, Yaltonen V. Longterm outcome of ciprofloxacin treatment in severe perianal or fistulous Crohn\u2019s disease. Gastroenterology. 1993;104:A793.","journal-title":"Gastroenterology"},{"key":"1331_CR16","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1111\/j.1572-0241.2007.01741.x","volume":"103","author":"S Angelberger","year":"2008","unstructured":"Angelberger S, Reinisch W, Dejaco C, et\u00a0al. NOD2\/CARD15 gene variants are linked to failure of antibiotic treatment in perianal fistulating Crohn\u2019s disease. Am J Gastroenterol. 2008;103:1197\u20131202.","journal-title":"Am J Gastroenterol"},{"key":"1331_CR17","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/BF02054227","volume":"38","author":"PR Williamson","year":"1995","unstructured":"Williamson PR, Hellinger MD, Larach SW, Ferrara A. Twenty-year review of the surgical management of perianal Crohn\u2019s disease. Dis Colon Rectum. 1995;38:389\u2013392.","journal-title":"Dis Colon Rectum"},{"key":"1331_CR18","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1007\/s10620-005-2769-4","volume":"50","author":"RL West","year":"2005","unstructured":"West RL, Van der Woude CJ, Endtz HP, et\u00a0al. Perianal fistulas in Crohn\u2019s disease are predominantly colonized by skin flora: implications for antibiotic treatment? Dig Dis Sci. 2005;50:1260\u20131263.","journal-title":"Dig Dis Sci"},{"key":"1331_CR19","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/35079107","volume":"411","author":"JP Hugot","year":"2001","unstructured":"Hugot JP, Chamaillard M, Zouali H, et\u00a0al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn\u2019s disease. Nature. 2001;411:599\u2013603.","journal-title":"Nature"},{"key":"1331_CR20","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/35079114","volume":"411","author":"Y Ogura","year":"2001","unstructured":"Ogura Y, Bonen DK, Inohara N, et\u00a0al. A frameshift mutation in NOD2 associated with susceptibility to Crohn\u2019s disease. Nature. 2001;411:603\u2013606.","journal-title":"Nature"},{"key":"1331_CR21","doi-asserted-by":"crossref","first-page":"5509","DOI":"10.1074\/jbc.C200673200","volume":"278","author":"N Inohara","year":"2003","unstructured":"Inohara N, Ogura Y, Fontalba A, et\u00a0al. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn\u2019s disease. J Biol Chem. 2003;278:5509\u20135512.","journal-title":"J Biol Chem"},{"key":"1331_CR22","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1126\/science.1104911","volume":"307","author":"KS Kobayashi","year":"2005","unstructured":"Kobayashi KS, Chamaillard M, Ogura Y, et\u00a0al. NOD2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science. 2005;307:731\u2013734.","journal-title":"Science"},{"key":"1331_CR23","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1136\/gut.2003.032805","volume":"53","author":"J Wehkamp","year":"2004","unstructured":"Wehkamp J, Harder J, Weichenthal M, et\u00a0al. NOD2 (CARD15) mutations in Crohn\u2019s disease are associated with diminished mucosal alpha-defensin expression. Gut. 2004;53:1658\u20131664.","journal-title":"Gut"},{"key":"1331_CR24","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1053\/gast.2003.50019","volume":"124","author":"DK Bonen","year":"2003","unstructured":"Bonen DK, Ogura Y, Nicolae DL, et\u00a0al. Crohn\u2019s disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan. Gastroenterology. 2003;124:140\u2013146.","journal-title":"Gastroenterology"},{"key":"1331_CR25","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.cgh.2009.05.001","volume":"7","author":"L Henckaerts","year":"2009","unstructured":"Henckaerts L, Van Steen K, Verstreken I, et\u00a0al. Genetic risk profiling and prediction of disease course in Crohn\u2019s disease patients. Clin Gastroenterol Hepatol. 2009;7:972\u2013980. e2.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1331_CR26","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1572-0241.2005.40705.x","volume":"100","author":"V Annese","year":"2005","unstructured":"Annese V, Lombardi G, Perri F, et\u00a0al. Variants of CARD15 are associated with an aggressive clinical course of Crohn\u2019s disease\u2014an IG-IBD study. Am J Gastroenterol. 2005;100:84\u201392.","journal-title":"Am J Gastroenterol"},{"key":"1331_CR27","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1136\/gut.2005.081950a","volume":"55","author":"EF Stange","year":"2006","unstructured":"Stange EF, Travis SP, Vermeire S, et\u00a0al. European Crohn\u2019s and Colitis Organisation. European evidence based consensus on the diagnosis and management of Crohn\u2019s disease: definitions and diagnosis. Gut. 2006;55:i1\u2013i15.","journal-title":"Gut"},{"key":"1331_CR28","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1056\/NEJM199905063401804","volume":"340","author":"DH Present","year":"1999","unstructured":"Present DH, Rutgeerts P, Targan S, et\u00a0al. Infliximab for the treatment of fistulas in patients with Crohn\u2019s disease. N Engl J Med. 1999;340:1398\u20131405.","journal-title":"N Engl J Med"},{"key":"1331_CR29","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1053\/gast.2002.31072","volume":"122","author":"WJ Sandborn","year":"2002","unstructured":"Sandborn WJ, Feagan BG, Hanauer SB, et\u00a0al. A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn\u2019s disease. Gastroenterology. 2002;122:512\u2013530.","journal-title":"Gastroenterology"},{"key":"1331_CR30","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1086\/341124","volume":"71","author":"S Vermeire","year":"2002","unstructured":"Vermeire S, Wild G, Kocher K, et\u00a0al. CARD15 genetic variation in a Quebec population: prevalence, genotype-phenotype relationship, and haplotype structure. Am J Hum Genet. 2002;71:74\u201383.","journal-title":"Am J Hum Genet"},{"key":"1331_CR31","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1086\/339432","volume":"70","author":"S Lesage","year":"2002","unstructured":"Lesage S, Zouali H, C\u00e9zard JP, et\u00a0al. CARD15\/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet. 2002;70:845\u2013857.","journal-title":"Am J Hum Genet"},{"key":"1331_CR32","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1053\/gast.2002.35393","volume":"123","author":"MT Abreu","year":"2002","unstructured":"Abreu MT, Taylor KD, Lin YC, et\u00a0al. Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn\u2019s disease. Gastroenterology. 2002;123:679\u2013688.","journal-title":"Gastroenterology"},{"key":"1331_CR33","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1136\/gut.52.4.558","volume":"52","author":"T Heli\u00f6","year":"2003","unstructured":"Heli\u00f6 T, Halme L, Lappalainen M, et\u00a0al. CARD15\/NOD2 gene variants are associated with familially occurring and complicated forms of Crohn\u2019s disease. Gut. 2003;52:558\u2013562.","journal-title":"Gut"},{"key":"1331_CR34","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1111\/j.1572-0241.2004.40304.x","volume":"99","author":"M Economou","year":"2004","unstructured":"Economou M, Trikalinos TA, Loizou KT, Tsianos EV, Ioannidis JP. Differential effects of NOD2 variants on Crohn\u2019s disease risk and phenotype in diverse populations: a metaanalysis. Am J Gastroenterol. 2004;99:2393\u20132404.","journal-title":"Am J Gastroenterol"},{"key":"1331_CR35","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.3748\/wjg.v11.i3.457","volume":"11","author":"PL Lakatos","year":"2005","unstructured":"Lakatos PL, Lakatos L, Szalay F, et\u00a0al. Toll-like receptor 4 and NOD2\/CARD15 mutations in Hungarian patients with Crohn\u2019s disease: phenotype-genotype correlations. World J Gastroenterol. 2005;11:1489\u20131495.","journal-title":"World J Gastroenterol"},{"key":"1331_CR36","doi-asserted-by":"crossref","first-page":"7097","DOI":"10.3748\/wjg.v12.i44.7097","volume":"12","author":"G Radford-Smith","year":"2006","unstructured":"Radford-Smith G, Pandeya N. Associations between NOD2\/CARD15 genotype and phenotype in Crohn\u2019s disease\u2014Are we there yet? World J Gastroenterol. 2006;12:7097\u20137103.","journal-title":"World J Gastroenterol"},{"key":"1331_CR37","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/ibd.3780060103","volume":"6","author":"C Gasche","year":"2000","unstructured":"Gasche C, Scholmerich J, Brynskov J, et\u00a0al. A simple classification of Crohn\u2019s disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis. 2000;6:8\u201315.","journal-title":"Inflamm Bowel Dis"},{"key":"1331_CR38","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1155\/2005\/269076","volume":"19","author":"MS Silverberg","year":"2005","unstructured":"Silverberg MS, Satsangi J, Ahmad T, et\u00a0al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19:5\u201336.","journal-title":"Can J Gastroenterol"},{"key":"1331_CR39","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1136\/gut.26.3.279","volume":"26","author":"HD Janowitz","year":"1985","unstructured":"Janowitz HD, Croen EC, Sachar DB. Role of the faecal stream in the maintenance of Crohn\u2019s colitis. Gut. 1985;26:279\u2013284.","journal-title":"Gut"},{"key":"1331_CR40","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1007\/s002680010250","volume":"24","author":"T Yamamoto","year":"2000","unstructured":"Yamamoto T, Allan RN, Keighley MR. Effect of fecal diversion alone on perianal Crohn\u2019s disease. World J Surg. 2000;24:1258\u20131262.","journal-title":"World J Surg"},{"key":"1331_CR41","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1007\/s10350-007-9077-3","volume":"50","author":"WB Gaertner","year":"2007","unstructured":"Gaertner WB, Decanini A, Mellgren A, et\u00a0al. Does infliximab infusion impact results of operative treatment for Crohn\u2019s perianal fistulas? Dis Colon Rectum. 2007;50:1754\u20131760.","journal-title":"Dis Colon Rectum"},{"key":"1331_CR42","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/BF00341224","volume":"7","author":"S Nordgren","year":"1992","unstructured":"Nordgren S, Fasth S, Hult\u00e9n L. Anal fistulas in Crohn\u2019s disease: incidence and outcome of surgical treatment. Int J Colorectal Dis. 1992;7:214\u2013218.","journal-title":"Int J Colorectal Dis"},{"key":"1331_CR43","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.gastro.2003.08.025","volume":"125","author":"WJ Sandborn","year":"2003","unstructured":"Sandborn WJ, Fazio VW, Feagan BG, Hanauer SB. American Gastroenterological Association Clinical Practice Committee. AGA technical review on perianal Crohn\u2019s disease. Gastroenterology. 2003;125:1508\u20131530.","journal-title":"Gastroenterology"},{"key":"1331_CR44","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF02053858","volume":"38","author":"L Halme","year":"1995","unstructured":"Halme L, Sainio AP. Factors related to frequency, type, and outcome of anal fistulas in Crohn\u2019s disease. Dis Colon Rectum. 1995;38:55\u201359.","journal-title":"Dis Colon Rectum"},{"key":"1331_CR45","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1203\/01.PDR.0000112100.61253.85","volume":"55","author":"P Ahrens","year":"2004","unstructured":"Ahrens P, Kattner E, K\u00f6hler B, et\u00a0al. Mutations of genes involved in the innate immune system as predictors of sepsis in very low birth weight infants. Pediatr Res. 2004;55:652\u2013656.","journal-title":"Pediatr Res"},{"key":"1331_CR46","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1007\/s00134-007-0722-z","volume":"33","author":"J Brenmoehl","year":"2007","unstructured":"Brenmoehl J, Herfarth H, Gl\u00fcck T, et\u00a0al. Genetic variants in the NOD2\/CARD15 gene are associated with early mortality in sepsis patients. Intensive Care Med. 2007;33:1541\u20131548.","journal-title":"Intensive Care Med"},{"key":"1331_CR47","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/1471-2334-6-122","volume":"6","author":"JE Hartog den","year":"2006","unstructured":"den Hartog JE, Ouburg S, Land JA, et\u00a0al. Do host genetic traits in the bacterial sensing system play a role in the development of Chlamydia trachomatis-associated tubal pathology in subfertile women? BMC Infect Dis. 2006;6:122.","journal-title":"BMC Infect Dis"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-010-1331-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-010-1331-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-010-1331-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,7]],"date-time":"2020-06-07T00:08:44Z","timestamp":1591488524000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-010-1331-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,15]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["1331"],"URL":"https:\/\/doi.org\/10.1007\/s10620-010-1331-1","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,15]]}}}